Abstract:Yuan Liao, 1, * Rui-zhi Tan, 1, * Jian-chun Li, 1 Tong-tong Liu, 1 Xia Zhong, 1 Ying Yan, 1 Jie-ke Yang, 1 Xiao Lin, 1 Jun-ming Fan, 2 Li Wang 1 1 Research Center of Combine Traditional Chinese and Western Medicine, Affiliated Traditional Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, People's Republic of China; 2 Chengdu Medical College, Chengdu, Sichuan 610000, People's Republic of China *These authors contributed equally to this work Correspondence: Li Wang Research Center of Combine Traditional Chinese and Western Medicine, Affiliated Traditional Medicine Hospital, Southwest Medical University, 319 # Zhongshan Road, Luzhou, Sichuan 646000, People's Republic of China Tel +86 0830 3161222 Email wangli120@swmu.edu.cn Purpose: Chronic kidney disease (CKD) is a global nephrotic syndrome characterized by chronic inflammation, oxidative stress and fibrosis in the kidney. Isoliquiritigenin (ISL), a flavonoid from licorice, has historically been reported to inhibit innate immune responses to inflammation and fibrosis in vivo. However, the effect of ISL on CKD progression is largely unknown. Materials and Methods: In this study, we employed the inflammatory and fibrotic models of LPS/TGF-β-induced bone marrow-derived macrophages (BMDM) in vitro and unilateral ureteral obstruction (UUO) model in vivo to explore the potential effects and mechanism of ISL on renal inflammation and fibrosis. Results: Our results manifest that ISL improved UUO-induced renal dysfunction and reduced tubular damage with a significantly downregulated mRNA expression and secretion of IL-1β, IL-6, TNF-α and MCP-1 in vitro and in vivo. It is worth noting that ISL can strongly inhibit the mRNA and protein expression of Mincle (macrophage-induced c-type lectin) in BMDM and UUO. ISL inhibited the phosphorylation of Syk and NF-kappa B and simultaneously reduced the expression of α-SMA and Col III in vivo and in vitro. More interestingly, when dealing with TDB, a ligand of Mincle, it revealed significant reversal of protein expression levels as that observed with ISL. The expressions of IL-1β, IL-6, TNF-α, iNOS, p-Syk, p-NF-kappa B, α-SMA and FN in BMDM inflammatory model were significantly upregulated with TDB treatment. This confirms that ISL inhibits inflammation and fibrosis of macrophage by suppressing Mincle/Syk/NF-kappa B signaling pathway. Conclusion: To conclude, ISL protects UUO-induced CKD by inhibiting Mincle-induced inflammation and suppressing renal fibrosis, which might be a specific renal protective mechanism of ISL, making it a novel drug to ameliorate CKD. Keywords: Isoliquiritigenin, Mincle, macrophage, CKD, inflammation, fibrosis

Isoliquiritigenin Alleviates Diabetic Kidney Disease via Oxidative Stress and the TLR4/NF-κB/NLRP3 Inflammasome Pathway

Isoliquiritigenin Prevents the Development of Nephropathy by an HFD in Rats Through the Induction of Antioxidant Production and Inhibition of the MD-3 2/TLR4/NF-κB Pathway

Isoliquiritigenin Attenuates Diabetic Cardiomyopathy Via Inhibition of Hyperglycemia-Induced Inflammatory Response and Oxidative Stress.

Dddt_a_243420 1455..1468

Isoliquiritigenin Attenuates UUO-Induced Renal Inflammation and Fibrosis by Inhibiting Mincle/Syk/NF-Kappa B Signaling Pathway

Licorice Extract Isoliquiritigenin Protects Endothelial Function in Type 2 Diabetic Mice

Isoliquiritigenin attenuates LPS-induced AKI by suppression of inflammation involving NF-κB pathway

Isoliquiritigenin Attenuates LPS-induced Acute Kidney Injury Through Suppression of HMGB1 Pathway in Renal Tubular Against Ferritinophagy

Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation

Irbesartan Ameliorates Diabetic Nephropathy by Activating the Nrf2/Keap1 Pathway and Suppressing NLRP3 Inflammasomes in Vivo and in Vitro

Isomangiferin Attenuates Renal Injury in Diabetic Mice Via Inhibiting Inflammation.

Isoliquiritin Ameliorates Cisplatin-Induced Renal Proximal Tubular Cell Injury by Antagonizing Apoptosis, Oxidative Stress and Inflammation

Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease

Syringaresinol Attenuates Kidney Injury by Inhibition of Pyroptosis Via Activating the Nrf2 Antioxidant Pathway in Diabetic Nephropathy

GSK-3beta Inhibitor Induces Expression of Nrf2/TrxR2 Signaling Pathway to Protect Against Renal Ischemia/Reperfusion Injury in Diabetic Rats

Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis

1,25(OH)2D3 Provides Protection Against Diabetic Kidney Disease by Downregulating the TLR4-MyD88-NF-κB Pathway

Isoliquiritigenin limits inflammasome activation of macrophage via docking into Syk to alleviate murine non‐alcoholic fatty liver disease

Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease

Kirenol alleviates diabetic nephropathy via regulating TGF-β/Smads and the NF-κB signal pathway

Protective Effect of Lycorine Hydrochloride Against Diabetic Nephropathy in High-Fat Diet and Streptozotocin-Induced Diabetic Mice